Yahoo Web Search

Search results

    • AbbVie (NYSE:ABBV) Price Target Cut to $187.00

      ETF DAILY NEWS· 3 days ago

      AbbVie (NYSE:ABBV – Get Free Report) had its target price cut by equities researchers at Barclays from $195.00 to $187.00 in a research report issued on Monday, Benzinga reports ...

    • Trials to watch: Four ALS drugs to keep an eye on

      Trials to watch: Four ALS drugs to keep an eye on

      Clinical Trials Arena via Yahoo Finance· 4 days ago

      “The good news is the pipeline is healthy for ALS, which is important, especially given what has happened with Amylyx’s drug which was...of the Clinical...